SAVANNAH, Ga.--(BUSINESS WIRE)--Today, at the 2013 World Molecular Imaging Congress (WMIC), Bruker (NASDAQ: BRKR) introduced a new multimodal animal bed enabling multiple sequential imaging sessions in preclinical research with robust repositioning between scans, while avoiding unwanted motion of the animal during the investigation. This innovation optimizes results for image fusion, combined processing and evaluation of preclinical research applications requiring multiple imaging modalities across multiple systems. The multimodal animal bed is compatible with most Bruker preclinical imaging systems, including the BioSpec® and ICON™ systems for MRI, Albira™ for PET/SPECT/CT, SKYSCAN 1176 for micro-CT, and Xtreme for Optical Molecular Imaging.
Help employers find you! Check out all the jobs and post your resume.